BioCryst Pharmaceuticals Inc. (BCRX) Business Metric Overview - Stocknear

BioCryst Pharmaceuticals ...

NASDAQ: BCRX · Real-Time Price · USD
8.27
0.00 (0.00%)
At close: Sep 05, 2025, 3:59 PM
8.30
0.36%
After-hours: Sep 05, 2025, 05:51 PM EDT

BioCryst Pharmaceuticals Revenue Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Mar 31, 2018
Collaborative and Other Research and Development Revenue 1.75M 237.33M 1.02M 1.34M 3.49M 239.41M 1.45M 1.99M 612K 78.06M 75.21M 64.89M 30K 903K 1.53M 1.4M 2.08M 2.27M 3.37M 2.83M 2.66M 21.43M 932K 752K 1.89M 954K 931K 315K
Collaborative and Other Research and Development Revenue Growth -99.26% +23190.48% -24.24% -61.45% -98.54% +16365.47% -26.82% +224.67% -99.22% +3.79% +15.91% +216193.33% -96.68% -41.02% +9.28% -32.81% -8.27% -32.55% +19.21% +6.28% -87.59% +2199.25% +23.94% -60.13% +97.69% +2.47% +195.56% n/a
Product Revenue 143.79M n/a 116.07M 107.99M 89.27M n/a 85.29M n/a n/a n/a 14K 104K n/a n/a n/a n/a n/a 605K 2.48M n/a 218K 15.52M 335K n/a 1.68M n/a n/a n/a
Product Revenue Growth n/a n/a +7.48% +20.96% n/a n/a n/a n/a n/a n/a -86.54% n/a n/a n/a n/a n/a n/a -75.59% n/a -100.00% -98.60% +4532.54% n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 87.38M 82.47M 80.47M 65.08M 61.21M 59.36M 64.38M 50.65M 51M 47.87M 50.15M 36.92M 38.02M 34.28M 35.39M 34.99M 26.32M 22.11M 20.99M 17.2M 13.88M 15.87M 10.49M 11.73M 8.66M 6.24M 4.49M 7.92M 9.49M 7.61M 4.7M 3.34M 2.83M 3.06M 2.56M 2.76M 2.72M 3.21M 2.72M 2.73M 3.53M 4.06M
Selling, General, and Administrative Revenue Growth +5.96% +2.48% +23.64% +6.32% +3.12% -7.79% +27.12% -0.68% +6.54% -4.56% +35.85% -2.89% +10.89% -3.12% +1.13% +32.92% +19.04% +5.38% +22.05% +23.86% -12.49% +51.25% -10.62% +35.52% +38.81% +38.93% -43.33% -16.53% +24.75% +61.96% +40.53% +17.96% -7.33% +19.41% -7.08% +1.17% -15.19% +18.04% -0.37% -22.72% -12.98% n/a
Research and Development Revenue 43.39M 37.27M 49.44M 41.08M 37.62M 46.49M 70.05M 46.88M 51.25M 48.39M 73.21M 52.74M 61.99M 65.36M 63.53M 49.97M 52.87M 42.44M 35.35M 30.25M 27.5M 29.87M 26.77M 25.12M 27.68M 27.49M 23.43M 22.01M 21.01M 18.44M 16.92M 17.51M 15.76M 16.77M 12.16M 14.11M 14.17M 20.58M 19.05M 20.07M 16.52M 17.12M
Research and Development Revenue Growth +16.41% -24.62% +20.35% +9.19% -19.08% -33.63% +49.43% -8.52% +5.91% -33.90% +38.81% -14.92% -5.16% +2.88% +27.13% -5.49% +24.60% +20.03% +16.89% +9.99% -7.93% +11.55% +6.58% -9.25% +0.68% +17.34% +6.48% +4.74% +13.93% +8.96% -3.34% +11.10% -6.03% +37.93% -13.80% -0.43% -31.16% +8.04% -5.08% +21.44% -3.48% n/a